magnolol has been researched along with baicalein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chen, CC; Chen, SA; Chiang, HT; Li, HF; Lo, YK; Wu, SN | 1 |
2 other study(ies) available for magnolol and baicalein
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Stimulation of the BK(Ca) channel in cultured smooth muscle cells of human trachea by magnolol.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Evans Blue; Flavanones; Flavonoids; Glycyrrhetinic Acid; Humans; Large-Conductance Calcium-Activated Potassium Channels; Lignans; Membrane Potentials; Muscle, Smooth; Niflumic Acid; Potassium; Potassium Channels; Potassium Channels, Calcium-Activated; Trachea | 2002 |